Indirectly, mitoxantrone induces anti-tumor immunity against fibrosarcoma, characterized mainly by enhanced CD8+ T cell activation, through myeloid cell-derived IL-1β produced by NLRP3 inflammasomes [217]. Here, CD8A is linked to neoplasm.